Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
Current Opinion in Pulmonary Medicine|July 13, 2015
Practical considerations in the pharmacologic treatment of idiopathic pulmonary fibrosisChristopher S King, Steven D Nathan
The Lancet. Respiratory Medicine|September 8, 2016
Idiopathic pulmonary fibrosis: effects and optimal management of comorbiditiesChristopher S King, Steven D Nathan
Drug Design, Development and Therapy|July 26, 2014
Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?Steven D Nathan, Christopher S King
Current Opinion in Pulmonary Medicine|August 1, 2019
Pulmonary hypertension due to interstitial lung diseaseChristopher S King, Steven D Nathan
Respiratory Research|July 3, 2025
The potential clinical implications of slow vital capacity in patients with idiopathic pulmonary fibrosisHo Cheol Kim, Sydney Guthrie, Christopher S King, et al.
Pulmonary Circulation|July 17, 2025
Hemodynamic Patterns in Interstitial Lung Disease: A Snapshot of Clinical Practice and a Roadmap for Future TrialsHo Cheol Kim, Christopher S King, Christopher A Thomas, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 28, 2009
Native lung complications in single-lung transplant recipients and the role of pneumonectomyChristopher S King, Sandeep Khandhar, Nelson Burton, et al.
Chest|May 22, 2017
Ventricular Diastolic Pressure Ratio as a Marker of Treatment Response in Pulmonary HypertensionArun Jose, Christopher S King, Oksana A Shlobin, et al.
Pageof 30